CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
New Haven, Connecticut, United States and 61 other locations
This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...
Phase 2
New Haven, Connecticut, United States and 80 other locations
The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM...
Phase 2
Valhalla, New York, United States and 22 other locations
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...
New London, Connecticut, United States and 132 other locations
Clinical trials
Research sites
Resources
Legal